H
Huihe Medical
Brings health and happiness to people with continuous innovation and excellent quality
About Huihe Medical
Huihe Medical, formally Shanghai Huihe Medical Technology Co., Ltd., is a medical device company focused on developing interventional treatments for structural heart disease. Founded in May 2019 by Lin Lin, a former cardiologist, the company directs its efforts toward addressing unmet clinical needs in cardiac surgery. Lin's experience in cardiology, particularly in structural heart disease, informed the company's direction, leading to the pursuit of minimally invasive solutions for complex heart conditions like combined mitral and tricuspid valve disease.
The company operates in the cardiovascular intervention market, developing and producing medical devices for hospitals and cardiac surgeons. Its business model centers on the research, development, and eventual commercialization of its proprietary medical technologies. Huihe Medical generates revenue through the sale of these devices and has secured substantial funding to support its operations and growth. The company has successfully raised capital through multiple financing rounds, including an Angel round in 2019, a Series A round in 2020, and subsequent B and C rounds, attracting investment from firms like IDG Capital, Sherpa Capital, and Guotai Junan Innovation Investment.
Huihe Medical's flagship product is the K-Clip™, a transcatheter tricuspid annulus repair system designed to treat tricuspid regurgitation, a condition where the heart's tricuspid valve fails to close properly. This system is based on the Kay's surgical annuloplasty technique, adapted for a minimally invasive, transvascular approach that avoids open-heart surgery. The procedure has a reported average time of just 30 minutes, which presents a lower risk and faster recovery for patients, particularly the elderly. The K-Clip™ has completed humanitarian and confirmatory clinical trials in China and is undergoing studies for CE marking in Europe. Another key product is the S-wan, a dual-pole steerable sheath that recently received NMPA approval in China, making it the only domestically produced device of its kind.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 8
- Open positions
- None listed
- Dealroom signal
- 40.7/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Surgery, Cardiology and cardiovascular, Chronic Disease, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Dec 2025 | $28M | $1.1B | China Taiping Insurance · Sherpa Venture Partners | ↗ |
| SERIES COther financing | Dec 2022 | $28M | $110M | Shanghai Kechuang Fund | ↗ |
Growth signals
Latest recorded traffic for Huihe Medical is 890 monthly website visits, up 456.3% over the last three months. Huihe Medical's team declined 11.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Huihe Medical in its local ecosystem
The Huihe Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
- SFShanghai Kechuang Fund
China Taiping Insurance
Sherpa Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Huihe Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Huihe Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







